As of 2025-10-28, the Intrinsic Value of Dyne Therapeutics Inc (DYN) is -14.51 USD. This DYN valuation is based on the model Peter Lynch Fair Value. With the current market price of 17.12 USD, the upside of Dyne Therapeutics Inc is -184.76%.
Based on its market price of 17.12 USD and our intrinsic valuation, Dyne Therapeutics Inc (DYN) is overvalued by 184.76%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -14.51 - -14.51 | -14.51 | -184.76% |
| P/E | (40.81) - (43.88) | (42.30) | -347.1% |
| DDM - Stable | (18.49) - (66.21) | (42.35) | -347.4% |
| DDM - Multi | (1.34) - (3.82) | (1.99) | -111.6% |
| Market Cap (mil) | 2,435.49 |
| Beta | 1.70 |
| Outstanding shares (mil) | 142.26 |
| Enterprise Value (mil) | 2,049.26 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.47% |
| Cost of Debt | 5.00% |
| WACC | 7.57% |